Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma
Clinical trial NCT03064763 · COMPLETED
Trial details
- NCT number
- NCT03064763
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2020-08-03
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.